This inventor holds 2 USPTO granted patents. Top assignees: Chung Ang University Industry Academic Cooperation, Chungbuk National University Industry-Academic Cooperation Foundation, Industry Academic Cooperation Foundation Hallym University. Active years: 2015-2018.
Company Filing History:
2 out of 208 
1 out of 46 
1 out of 21 Years Active: 2015-2018
Title: Innovations of Sung Wook Wee in Glaucoma and Corneal Endothelial Treatment
Introduction
Sung Wook Wee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma and corneal endothelial wounds. With a total of 2 patents, his work focuses on innovative pharmaceutical compositions that leverage the properties of angiogenin.
Latest Patents
One of his latest patents is titled "Angiogenin for treatment of glaucoma." This invention provides a pharmaceutical composition aimed at preventing or treating glaucoma. The composition includes angiogenin or a fragment thereof as an active ingredient. The invention highlights how angiogenin activates aqueous humor outflow through increased NO generation, Schlemm's canal expansion, and intercellular interval widening, ultimately reducing intraocular pressure. This makes angiogenin a promising candidate for glaucoma prevention and treatment.
Another significant patent is "Pharmaceutical composition for treatment of corneal endothelial wounds containing angiogenin." This composition is designed to treat corneal endothelium wounds, utilizing angiogenin as an effective ingredient. The invention introduces a new topical therapeutic use of angiogenin, which activates the PI3K/Akt/eNOS pathway in ocular corneal endothelium. This activation enhances the migration and proliferation of corneal endothelial cells, which are typically incapable of self-proliferation, thereby promoting the prevention and treatment of corneal endothelial cell wounds.
Career Highlights
Sung Wook Wee has been associated with prominent institutions such as Chung Ang University Industry Academic Cooperation and Chungbuk National University Industry-Academic Cooperation Foundation. His work in these organizations has facilitated advancements in research and development in the field of ophthalmology.
Collaborations
He has collaborated with notable colleagues, including Yeoun Sook Chun and Kyoung Woo Kim. These partnerships have contributed to the successful development of his innovative patents.
Conclusion
Sung Wook Wee's contributions to the treatment of glaucoma and corneal endothelial wounds through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new therapeutic options in ophthalmology.